COVID-19 Vaccine Update; Celecoxib Oral Solution OK'd for Migraine

Inbox

x

MPR Daily Dose <editor@email.empr.com> Unsubscribe

3:03 AM (10 hours ago)

to me

If you are having trouble viewing this email, click here.

MUST READS COVID-19 mRNA Vaccine Candidates Advancing Through the Pipeline Celecoxib Oral Solution Approved for Acute Migraine Treatment Tabrecta Approved for METex14 Metastatic Non-Small Cell Lung Cancer Recarbrio Noninferior to Pip/Tazo for Hospital-Acquired, Ventilator-Associated Bacterial Pneumonia Microbiome-Based Therapy Looks Promising for Recurrent C. Difficile Infection COVID-19 Resource Center CME/CE Spotlight Navigating the Sleep-Wake Cycle: A Guided 3-D Animation AMA PRA Category 1 Credit(s)TM, CE for Pharmacists CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME